Engaging in partnerships to combat vector-borne diseases is a key aspect of our 360° Vector Control approach. Sharing knowledge and know-how inspires us and provides the opportunity to share new ideas on prevention and control across geographically relevant areas.


Partnership for us is about sharing common objectives, with eachpartner contributing their specific strengths and resources. These canrange from bilateral or multi-stakeholder initiatives with governmentsand NGOs, to collaborative research projects. We believe that this is themost effective way to fight vector-borne diseases and improve thequality of people’s lives.

Research and Development

While we maintain our own laboratories in order to support the development and entomological testing of our various vector control products, we recognise the importance of engaging external expertise to provide a more rigorous and robust testing environment. The development of a new vector control product requires significant investment in time and resources. Therefore it is critically important that this development takes into account a diverse range of external conditions and testing environments to remain relevant in the long-term.

London School of Hygiene and Tropical Medicine (LSHTM) is one of the world's leading research and postgraduate teaching institutions in the field of public health. Bayer works in collaboration with LSHTM to conduct laboratory and field evaluations of new products through privately funded research trials and as a WHOPES Collaborating Centre. Each year we also provide support to Masters students who are undertaking research in the field of vector-borne disease.

LSHTM website

The Innovative Vector Control Consortium (IVCC) works to improve health outcomes by supporting the development of new vector control tools, increasing the effectiveness and efficiency of disease-transmitting-insect control and ultimately saving lives.

Bayer is proud to be part of the IVCC since 2008. From this collaboration, we have successfully brought a longer lasting indoor residual spray formulation K-Othrine PolyZone, through the WHOPES process.

IVCC website

Bayer collaborates with the French research organisation Institut de Recherche pour le Développement (IRD), more specifically the Laboratoire de Lutte contre les Insectes Nuisibles. The institute, unique in Europe, addresses international development issues. The Montpellier IRD centre specializes in biology and the control of disease vectors.

IRD website

Bayer cooperates with Liverpool School of Tropical Medicine (LSTM), the first institution in the world dedicated to tropical disease. LSTM is one of the main international postgraduate centres devoted to research in order to combat malaria, dengue, lymphatic filariasis, tuberculosis, HIV/AIDS and other diseases.
LSTM website

Contributing to Guidelines and Policy Development

Bayer works closely with the WHO / Global Malaria Program, the Department of Control of Neglected Tropical Diseases and the WHO Pesticide Evaluation Scheme (WHOPES). The latter has also established the Global Collaboration for Development of Pesticides for Public Health (GCDPP) in order to provide a forum for exchange of information on the pesticide development and to facilitate the search for alternative, safe and more cost-effective solutions. Bayer is a member of GCDPP.

The Roll Back Malaria (RBM) Partnership is the global framework for a malaria-free world, uniting more than 500 partners and implementing coordinated actions against the disease. Bayer is represented in the private sector delegation on the RBM Board and is active with experts in the various RBM Vector Control working groups.

RBM website

IRAC is an international group of more than 150 members of the Crop Protection Industry, organised by sector and region, to advise on the prevention and management of insecticide resistance. IRAC facilitates communication and education on insecticide resistance and promotes development of resistance management strategies. This important role helps to maintain insecticide efficacy and sustainable vector control in public health.

IRAC Public Health

Network and Advocacy Organisations

The sustained success against vector borne diseases relies heavily upon continued commitments from large, diverse groups of stakeholders towards the common goal of disease elimination. There are a number of organisations that play a key role in raising awareness about these diseases (e.g. Roll Back Malaria and the Partnership for Dengue Control) and bringing a network of like-minded entities together.

GBCHealth is a coalition of companies and organizations committed to investing their resources to make a healthier world for their employees, for the communities in which they work and for the world at large. The mission of GBCHealth is to leverage the power and resources of the private sector to meet today’s most pressing global health challenges, with a focus on high-priority health goals and lower-resource settings where business can make a powerful positive impact. GBCHealth also has the private sector focal point role with the Roll Back Malaria Partnership, the Global Fund and the Corporate Alliance on Malaria in Africa (CAMA).

GBCHealth website